Lab Spinoff Causes Biotech Stir

Bookmark and Share

In a recent edition of The Economist, Ginkgo BioWorks was profiled as one of a handful of companies spurring biotechnological innovation. The iGem competition, which is also administered through the lab, was similarly cited as a model for understanding the path that biological engineering projects may take in the future. To read the full story, please click here; information on Ginkgo and iGem is available on their respective websites.